ALLONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Allogene Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.30−0.01 (-0.76%)
Close on Oct 19, 2026
- Market cap
- $427.61M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
SEC filings
40 of Allogene Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Aug 31, 2026 | Sep 2, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2026 | Jun 22, 2026 | SEC EDGAR |
| Current report | 8-K | May 28, 2026 | May 28, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 13, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 18, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 14, 2026 | Apr 15, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 13, 2026 | Apr 13, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 13, 2026 | Apr 13, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2026 | Mar 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 26, 2025 | Oct 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 13, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2025 | Aug 13, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 1, 2025 | Aug 1, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2025 | Jun 23, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 13, 2025 | May 13, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 18, 2025 | Apr 30, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 13, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 13, 2025 | Mar 13, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 19, 2025 | Feb 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 23, 2025 | Jan 29, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 11, 2024 | Nov 13, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 3, 2024 | Oct 7, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 7, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2024 | Aug 7, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2024 | Jun 10, 2024 | SEC EDGAR |
| Current report | 8-K | May 24, 2024 | May 31, 2024 | SEC EDGAR |
| Current report | 8-K | May 13, 2024 | May 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 13, 2024 | SEC EDGAR |
| Current report | 8-K | May 13, 2024 | May 13, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 5, 2024 | Apr 23, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 14, 2024 | SEC EDGAR |